ArticleBMJ (Clinical research ed.)2023

Using health technology assessment to inform insurance reimbursement of high technology medicines in China: an example of cancer immunotherapy.

Yingyao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.